Patents by Inventor Danielle McAnally

Danielle McAnally has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • APELIN RECEPTOR AGONISTS AND METHODS OF USE THEREOF
    Publication number: 20230339872
    Abstract: Provided herein are agonists of the apelin receptor for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions.
    Type: Application
    Filed: April 28, 2023
    Publication date: October 26, 2023
    Inventors: Layton H. SMITH, Anthony B. PINKERTON, Paul HERSHBERGER, Patrick MALONEY, Danielle MCANALLY
  • Apelin receptor agonists and methods of use thereof
    Patent number: 11673873
    Abstract: Provided herein are agonists of the apelin receptor for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions.
    Type: Grant
    Filed: May 7, 2020
    Date of Patent: June 13, 2023
    Assignee: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
    Inventors: Layton H. Smith, Anthony B. Pinkerton, Paul Hershberger, Patrick Maloney, Danielle McAnally
  • SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS APELIN RECEPTOR AGONISTS
    Publication number: 20230037225
    Abstract: Provided herein are agonists of the apelin receptor of Formula (I): for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions.
    Type: Application
    Filed: May 12, 2022
    Publication date: February 2, 2023
    Inventors: Layton H. SMITH, Anthony B. PINKERTON, Paul HERSHBERGER, Patrick MALONEY, Danielle MCANALLY
  • Substituted pyrazolo[1,5-a]pyrimidines as apelin receptor agonists
    Patent number: 11345705
    Abstract: Provided herein are agonists of the apelin receptor of Formula (I): for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions.
    Type: Grant
    Filed: August 8, 2018
    Date of Patent: May 31, 2022
    Assignee: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
    Inventors: Layton H. Smith, Anthony B. Pinkerton, Paul Hershberger, Patrick Maloney, Danielle McAnally
  • APELIN RECEPTOR AGONISTS AND METHODS OF USE THEREOF
    Publication number: 20210040098
    Abstract: Provided herein are agonists of the apelin receptor for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions.
    Type: Application
    Filed: August 8, 2018
    Publication date: February 11, 2021
    Inventors: Layton H. SMITH, Anthony B. PINKERTON, Paul HERSHBERGER, Patrick MALONEY, Danielle MCANALLY
  • APELIN RECEPTOR AGONISTS AND METHODS OF USE THEREOF
    Publication number: 20200392092
    Abstract: Provided herein are agonists of the apelin receptor for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions.
    Type: Application
    Filed: May 7, 2020
    Publication date: December 17, 2020
    Inventors: Layton H. SMITH, Anthony B. PINKERTON, Paul HERSHBERGER, Patrick MALONEY, Danielle MCANALLY
  • Apelin receptor agonists and methods of use thereof
    Patent number: 10647689
    Abstract: Provided herein are agonists of the apelin receptor for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions.
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: May 12, 2020
    Assignee: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
    Inventors: Layton H. Smith, Anthony B. Pinkerton, Paul Hershberger, Patrick Maloney, Danielle McAnally
  • APELIN RECEPTOR AGONISTS AND METHODS OF USE THEREOF
    Publication number: 20180118698
    Abstract: Provided herein are agonists of the apelin receptor for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions.
    Type: Application
    Filed: April 28, 2016
    Publication date: May 3, 2018
    Inventors: Layton H. Smith, Anthony B. Pinkerton, Paul Hershberger, Patrick Maloney, Danielle McAnally